Shiferman Gregory L. 4
4 · Sage Therapeutics, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Award
Common Stock
2025-04-10+525→ 31,205 total - Tax Payment
Common Stock
2025-04-10$6.91/sh−176$1,216→ 31,029 total
Footnotes (1)
- [F1]On February 11, 2022, the reporting person was granted Performance Restricted Stock Units (PSUs) to acquire a total of 1,500 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 525 shares.